Approximately 10% of B-cell chronic lymphocytic leukemia (B-CLL) cases have structural chromosomal aberrations involving band 13q14. To evaluate a possible role of RBI gene deletions in B-CLL we investigated the malignant cells of 27 patients by molecular genetic and cytogenetic techniques. Four of
BRAC2 gene deletion is rare in chronic lymphocytic leukemia
✍ Scribed by Pilozzi, Emanuela; Fidler, Carrie; Boultwood, Jacqueline; Wainscoat, James S.
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 14 KB
- Volume
- 59
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Background Chronic lymphocytic leukemia (CLL) is characterized by accumulation of clonal, malignant CD5^+^, CD23^+^ B cells. In vivo, these cells have an antiapoptotic phenotype (high levels of Bcl‐2 and low levels of proapoptotic Bcl‐2 family proteins, such as Bax). Abnormal B cell
## Abstract Chronic lymphocytic leukemia (CLL) cells are characterized by several chromosomal lesions. Some of these aberrations imply chromosome breaks as a result of unrepaired double strand breaks (DSBs) in the DNA. The ATM (ataxia telangiectasia‐mutated) protein is the principal integrator of c